⚠️FOR RESEARCH PURPOSES ONLY
← Back to Research Database
ResearchPeptide

MOTS-c

Published Research

PubMed-indexed studies for MOTS-c

Research

The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.

Cell metabolism 2015
View on PubMed →
Research

Mitochondrial-Derived Peptide MOTS-c Suppresses Ovarian Cancer Progression by Attenuating USP7-Mediated LARS1 Deubiquitination.

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2024
View on PubMed →
Research

The mitochondrial-derived peptide MOTS-c relieves hyperglycemia and insulin resistance in gestational diabetes mellitus.

Pharmacological research 2022
View on PubMed →
Research

MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation.

Frontiers in endocrinology 2023
View on PubMed →
Research

Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases.

Diabetes & metabolism journal 2023
View on PubMed →
Research

The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress.

Cell metabolism 2018
View on PubMed →

Research-Grade MOTS-c

YPB.227
MOTS-c
Price range: $90.00 through $180.00
⚠️ For laboratory research only. Not for human use.